Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;69(6):428-435.
doi: 10.1111/idj.12509. Epub 2019 Aug 12.

Oral leukoplakia in the Sudan: clinicopathological features and risk factors

Affiliations

Oral leukoplakia in the Sudan: clinicopathological features and risk factors

Mayson B Mustafa et al. Int Dent J. 2019 Dec.

Abstract

Objectives: To analyse the clinical and histopathological features of oral leukoplakia (OL) in the Sudan, and to identify the risk factors associated with dysplastic and malignant changes.

Methods: Records of 117 cases with the diagnosis of OL at the Department of Oral Pathology in the period from 2010 to 2017 were reviewed.

Results: Of the 117 cases included in this study, 30 cases (25.6%) showed carcinoma in the initial diagnostic biopsy. The mean age at diagnosis was 59.8 years with a male/female ratio of 3.3:1. The lip (48.7%) and the gingiva (31.6%) were the predominantly affected sites. Multivariate regression analysis revealed that females were associated with 3.36-fold [95% confidence interval (CI), 1.36-10.76; P = 0.012] higher risk of malignant transformation compared with males. Verrucous leukoplakia was associated with 3.38-fold (95% CI, 1.12-10.19; P = 0.031) higher risk of malignant transformation compared with homogeneous leukoplakia. Exclusive Toombak dipping was the significant risk factor for the presence of dysplasia in OL (odds ratio, 9.35; 95% CI, 1.28-67.99; P = 0.027).

Conclusions: Clinical and histopathological features of OL were analysed and correlated. Toombak dipping was the significant risk factor for dysplastic changes, while female gender and verrucous leukoplakia were the factors associated with malignant transformation.

Keywords: Oral leukoplakia; Toombak; dysplasia; malignant transformation; risk factors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Clinical appearance of oral leukoplakia (OL) associated with Toombak dipping. (a) A superficial white lesion with no obvious thickness or roughness. (b) A white lesion located on the tongue showing a localised area of marked thickening and yellowish discolouration. (c) A diffuse white lesion extending on the lower lip and the gingiva associated with heavy thickening and grooving (verrucous). (d) An elevated white/yellowish lesion with marked thickening located on the buccal mucosa. Areas of erosions are noted at the margins.
Figure 2.
Figure 2.
Histopathological changes of oral leukoplakia (OL) associated with Toombak dipping. (a) Hyperkeratosis with mild dysplasia. (b) Moderate dysplasia with multiple nucleoli extending to the middle third. Focal mitotic activity and broad rete ridges are noted. (c) Severe dysplasia. Pseudoepitheliomatous, hyperparakeratotic stratified squamous epithelium with dysplastic changes extended above the mid of the spinous layer.

Similar articles

Cited by

References

    1. Saeed IE, Weng H-Y, Mohamed KH, et al. Cancer incidence in Khartoum, Sudan: first results from the Cancer Registry, 2009–2010. Cancer Med. 2014;3:1075–1084. - PMC - PubMed
    1. Idris AM, Ahmed HM, Mukhtar BI, et al. Descriptive epidemiology of oral neoplasms in Sudan 1970–1985 and the role of toombak. Int J Cancer. 1995;61:155–158. - PubMed
    1. Idris AM, Prokopczyk B, Hoffmann D. Toombak: a major risk factor for cancer of the oral cavity in Sudan. Prev Med. 1994;23:832–839. - PubMed
    1. Costea DE, Lukandu O, Bui L, et al. Adverse effects of Sudanese toombak vs. Swedish snuff on human oral cells. J Oral Pathol Med. 2010;39:128–140. - PubMed
    1. Idris AM, Ibrahim SO, Vasstrand EN, et al. The Swedish snus and the Sudanese toombak: are they different? Oral Oncol. 1998;34:558–566. - PubMed